Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Wafaa Mamilli (1967) will join the company as Chief Digital ...

The U.S. Department of Labor is looking to phase out sheltered work programs that are allowed to pay disabled workers less ...

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

Eli Lilly & Co. faced a skeptical Seventh Circuit Tuesday in arguing a lower court used a misplaced two-step process when it ...

Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three ...

The projected fair value for Eli Lilly is US$1,419 based on 2 Stage Free Cash Flow to Equity The US$978 analyst price target ...

Buddy Teevens, a 1974 Silver Lake grad, went on to play and coach football at Dartmouth. 'The Buddy Way' premiers on ESPN2 on ...

Nicole Ryf President Kenosha Area Business Alliance 5500 6th Ave., Kenosha Employees: 7 kaba.org Nicole Ryf, president of the ...

Now Novo Nordisk is required to provide insulin products at $35 per monthly prescription for customers paying with cash. The settlement also requires all three companies to use a texting system to ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...